Results for &quot;Xenotransplantation&quot; in Cancer

Fecal Transplants Show Mixed Results for Boosting Cancer Immunotherapy

New review reveals why fecal microbiota transplants sometimes help—and sometimes hurt—immune checkpoint inhibitor cancer treatments.

Apr 2, 2026 0

Scientists Create Cancer-Fighting CAR T Cells Directly Inside Living Mice

Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.

Press Release

Fecal Transplants Show Promise for Ulcerative Colitis and Cancer Immunotherapy

New research reveals how gut microbiome restoration could treat inflammatory bowel disease and boost cancer treatments.

Mar 29, 2026 2

New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection

Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.

Press Release

Mar 28, 2026 3

CAR-Engineered Immune Progenitors Open New Front in Cancer Immunotherapy

Scientists expand granulocyte-monocyte progenitors into a scalable CAR platform that infiltrates tumors and fights leukemia and solid cancers.

Jun 24, 2026 0

Engineered Macrophages Show Promise as New Cancer Immunotherapy Platform

Harvard researchers demonstrate that activated macrophages can both trigger immune responses and infiltrate tumors directly.

Mar 28, 2026 1

CRISPR Creates Cancer-Fighting CAR T Cells Directly Inside Living Mice

Revolutionary in vivo CRISPR technique creates more effective cancer-fighting immune cells without lab manipulation.

Podcast

Mar 28, 2026 1

New CAR-T Cell Therapy Reprograms Tumor Environment to Fight Metastatic Cancer

Engineered immune cells target harmful macrophages in tumors, transforming the cancer environment to boost natural anti-tumor immunity.

Mar 29, 2026 1

Four Leading Spatial Transcriptomics Platforms Benchmarked Across Human Tumors

Comprehensive comparison of Stereo-seq, Visium HD, CosMx, and Xenium platforms reveals key performance differences for cancer research applications.

Mar 27, 2026 13

Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial

Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.

Clinical Trial

Triple Combination Cancer Immunotherapy Shows Promise in Advanced Solid Tumors

Small trial tests novel three-drug approach combining immune checkpoint inhibitor, vaccine, and inflammation blocker for metastatic cancers.

Clinical Trial

Mar 29, 2026 1

Mitochondria-Targeted Therapy Creates Self-Reinforcing Cancer Cell Death Loop

Novel treatment triggers ferroptosis in cancer cells while activating immune responses that further enhance cancer cell death.

Apr 8, 2026 0

Gene Therapy Delivers Immune Signals Directly Into Brain Tumors in First Human Trial

A phase 1 trial shows Temferon — a gene-engineered stem cell therapy — safely delivers interferon-α into glioblastoma tumors with no dose-limiting toxicities.

Jun 2, 2026 0

Scientists Turn Cancer Cells Into Vaccine Factories to Fight Tumors From Within

Breakthrough therapy converts tumor cells into antigen-presenting cells that train immune system to destroy cancer.

Engineered Tumor Switches Destroy Glioblastoma While Building Lasting Immunity

Synthetic super-enhancers hijack glioblastoma's own regulatory circuits to trigger precise, tumor-only cell death and durable immune memory.

May 22, 2026 0

Engineered Antibodies Target KRAS Cancer Mutations for Precision Immunotherapy

Scientists develop antibodies that stabilize drug-modified KRAS mutations, enabling targeted immune responses across different genetic backgrounds.

Apr 9, 2026 0

Mitochondria-Targeted Cancer Therapy Shows Promise for Boosting Tumor Immunity

New review reveals how targeting mitochondria in cancer cells could overcome immunotherapy resistance and enhance anti-tumor responses.

Apr 8, 2026 0

Common Asthma Drug Target May Unlock Stalled Cancer Immunotherapy

Blocking CysLTR1 reprograms immunosuppressive neutrophils and reverses resistance to anti-PD1 checkpoint therapy in mice.

May 21, 2026 0

Cancer Cells Transfer Broken Mitochondria to Immune Cells to Escape Attack

New research reveals how tumors sabotage T cell metabolism by transferring dysfunctional mitochondria, offering fresh immunotherapy targets.